What is the diagnosis and recommended management for a patient with low serum iron, low ferritin, elevated transferrin, elevated total iron‑binding capacity (TIBC), elevated C‑reactive protein (CRP), and normal vitamin B12?

Diagnosis: Anemia of Mixed Origin (Iron Deficiency + Anemia of Chronic Disease)

This patient has combined iron deficiency anemia and anemia of chronic disease, as evidenced by ferritin levels between 6.5-11.5 ng/mL (well below 30 ng/mL) with elevated inflammatory markers (CRP 8.9 mg/L), requiring both iron replacement and investigation of the underlying inflammatory condition. 1

Diagnostic Interpretation

Iron Status Assessment

• Ferritin 6.5-11.5 ng/mL: This indicates absolute iron deficiency, as levels <15 ng/mL confirm depleted iron stores even in the presence of inflammation 2
• Low serum iron (24-26 µg/dL): Confirms inadequate circulating iron 1
• Elevated transferrin (374 mg/dL) and TIBC (524 µg/dL): Classic compensatory response to iron deficiency 2
• Normal vitamin B12 (1062 pg/mL): Rules out B12 deficiency as a contributing factor 1

Inflammatory Component

• Elevated CRP (8.9 mg/L): Indicates active inflammation, which complicates the clinical picture 1
• Ferritin between 6.5-11.5 ng/mL with inflammation present: When ferritin is between 30-100 ng/mL in the presence of inflammation, a combination of true iron deficiency and anemia of chronic disease is likely; however, this patient's ferritin is well below 30 ng/mL, confirming absolute iron deficiency despite the inflammatory state 1

Recommended Management Algorithm

Step 1: Identify and Treat Underlying Causes

Investigate sources of blood loss and inflammation:

• Gastrointestinal evaluation: Bidirectional endoscopy (EGD and colonoscopy) is indicated for adults with iron deficiency anemia to identify GI pathology including malignancy, particularly if there are no obvious alternative explanations 3
• Menstrual history: In premenopausal women, assess for heavy menstrual bleeding as a primary cause 2, 4
• Inflammatory conditions: Evaluate for inflammatory bowel disease, celiac disease, chronic kidney disease, heart failure, or malignancy given the elevated CRP 1, 2, 4
• Medication review: Check for NSAIDs, anticoagulants, or antiplatelet agents that may contribute to GI blood loss 2
• Dietary assessment: Evaluate iron intake, particularly in vegetarians/vegans, and assess for malabsorption syndromes 3, 4

Step 2: Iron Replacement Therapy

Initial approach based on clinical context:

Consider intravenous iron as first-line if:

• Ongoing blood loss is present 4, 5
• Chronic inflammatory conditions exist (IBD, CKD, heart failure) 2, 6, 4
• Malabsorption is suspected (celiac disease, post-bariatric surgery, atrophic gastritis) 6, 4
• Patient is in second or third trimester of pregnancy 4
• Severe anemia requiring rapid correction 6

Oral iron therapy (if IV iron not indicated):

• Ferrous sulfate 325 mg daily or on alternate days (alternate-day dosing may improve absorption and reduce side effects) 4
• Maximum 100 mg elemental iron per day in patients with inflammatory bowel disease 2
• Monitor for side effects: nausea, abdominal pain, constipation 6, 4
• If intolerant or non-responsive after 4-6 weeks, switch to intravenous iron 6, 5

Intravenous iron formulations:

• Available options include low molecular weight iron dextran, iron sucrose, ferric carboxymaltose, ferumoxytol, and iron isomaltoside 7
• Full replacement doses can be administered in minutes to hours 5
• Modern formulations have very low rates of serious adverse events 5

Step 3: Treatment Targets and Monitoring

Target parameters:

• Hemoglobin: Increase to 10-12 g/dL or normalization 1
• Ferritin: Target >100 µg/L in the presence of inflammation 1
• Transferrin saturation: Target >20% 8

Monitoring schedule:

• Recheck hemoglobin, ferritin, and iron studies after 4-6 weeks of oral therapy or 2-4 weeks after IV iron 6
• Long-term monitoring every 3-6 months for recurrence, as >50% of patients develop recurrent anemia within 1 year 1, 2

Step 4: Address the Inflammatory Component

Treat underlying inflammatory condition:

• Chronic inflammation is a key driver of anemia and must be addressed for optimal response 1
• Iron replacement alone is rarely sufficient without controlling the underlying inflammatory process 1
• In IBD patients, bringing disease into remission improves iron absorption and anemia metrics 2

Critical Pitfalls to Avoid

Do not rely solely on ferritin in inflammatory states: While this patient's ferritin is unequivocally low (<15 ng/mL), in general practice, ferritin levels up to 100 ng/mL may still represent iron deficiency when inflammation is present 1

Do not delay investigation: Even with an obvious inflammatory condition, GI evaluation should not be deferred, as concurrent GI pathology (including malignancy) may be present 3, 6

Do not undertreat: Anemia profoundly affects quality of life and is associated with increased morbidity including postsurgical complications and mortality risk 1

Do not assume oral iron will suffice: In the presence of inflammation (elevated CRP), oral iron absorption is impaired due to hepcidin upregulation, making IV iron more effective 7, 2, 5

Do not use ferritin alone for diagnosis: Calculate transferrin saturation (iron/TIBC × 100); a value <16-20% confirms iron deficiency even when ferritin interpretation is complicated by inflammation 1, 3